Today's Date
Study of Antithymocyte Globulin for Treatment of New-onset T1DM
(
START
)
ITN Protocol #:
ITN028AI
Branded Name:
START
ClinicalTrials.Gov ID:
NCT00515099Treatment Protocol #:
ATG
Therapeutic Area:
Type 1 Diabetes
Current Status:
Complete
Summary:
Effect of Antithymocyte Globulin on Preserving Beta-cell Function in New-onset Type 1 Diabetes Mellitus
Clinical Operations Associate Director & Manager
ITN Biostat
ITN Clinical Trial Physician
NIAID Project Manager
Rho Data Manager
Rho Scientist
Study Personnel:
